Trial Profile
Effects of linagliptine plus metformin versus metformin alone in prediabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2018
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Metformin
- Indications Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Oct 2018 Results evaluating the effect of linagliptin + metformin plus a lifestyle program on glucose metabolism, insulin secretion and beta cell function presented at the 54th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Oct 2018 Status changed from recruiting to completed.
- 05 Oct 2018 Results (n=25) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes